{
  "document_id": "CnsPharmaceuticalsInc_20200326_8-K_EX-10.1_12079626_EX-10.1_Development Agreement",
  "file_path": "data/CUAD_v1/full_contract_pdf/Part_I/Development/CnsPharmaceuticalsInc_20200326_8-K_EX-10.1_12079626_EX-10.1_Development Agreement.pdf",
  "text_length": 20804,
  "chunk_count": 28,
  "vector_store_path": "output/vector_stores/CnsPharmaceuticalsInc_20200326_8-K_EX-10.1_12079626_EX-10.1_Development Agreement",
  "summary": "acts and things reasonably necessary, if any, in connection with the performance of its obligation hereunder to carry out the intent of this\nAgreement.\n9.2 This Agreement contains the entire understanding of the Parties, and supersedes all prior agreements and understandings between the\nParties. This Agreement may be amended only by a written instrument signed by the Parties.\n9.3 The waiver by any Party of any terms or condition of this Agreement, or any part hereof, shall not be deemed a waiver of any other\nterm or condition of this Termination Agreement, or of any later breach of this Agreement.\n9.4 Any notice required by this Agreement will be given by personal delivery (including delivery by reputable messenger services such as\nFederal Express) or by prepaid, first class, certified mail, return receipt requested, addressed to:\nIf to WPD: If to CNS :\nWPD Pharmaceuticals sp. z o.o CNS Pharmaceuticals, Inc.\nAttention: CEO Attention: CEO\n\nARTICLE 7\nREPRESENTATIONS, WARRANTIES AND COVENANTS\n7.1 Each Party represents and warrants that:\n7.1.1 it is duly organized and validly existing under the laws of its state or country of incorporation, and has full corporate power\nand authority to enter into this Agreement and to carry out the provisions hereof\u037e\n7.1.2 it is duly authorized to execute and deliver this Agreement and to perform its obligations hereunder, and the person\nexecuting this Agreement on its behalf has been duly authorized to do so by all requisite corporate action\u037e\n7.1.3 this Agreement is legally binding upon it and enforceable in accordance with its terms\u037e that the execution, delivery and\nperformance of this Agreement by it does not conflict with any Agreement, instrument or understanding, oral or written, to which it is a party or by\nwhich it may be bound, nor violate any material law or regulation of any governmental entity having jurisdiction over it\u037e and\n\nARTICLE 8 INDEMNIFICATION\n8.1 WPD hereby agrees to hold harmless and indemnify CNS, its officers, affiliates, employees, and agents (the \u201c CNS Indemnitees \u201d) from\nand against any and all third party claims, demands, causes of actions, costs of suit and reasonable and documented attorney\u2019s fees (collectively\n\u201cClaims \u201d) caused by, arising out of, or resulting from WPD\u2019s, its employees, agents\u2019, affiliates\u2019, licensees\u2019, sublicensees\u2019 or subcontractors\u2019 (i)\nnegligence or willful misconduct\u037e (ii) breach of any warranty or representations set forth herein\u037e (iii) breach or alleged breach of third party\nintellectual property rights\u037e and (iv) use or sale of Development Products.\nARTICLE 9\nMISCELLANEOUS\n9.1 The Parties shall execute and deliver any and all additional papers, documents, and other instruments and shall do any and all further\nacts and things reasonably necessary, if any, in connection with the performance of its obligation hereunder to carry out the intent of this\nAgreement.\n\nhave used commercially reasonable efforts in good faith.\n2.3 The first Development Fees payment shall be due forty-five days after the end of the Calendar Quarter in which the first Sale of a\nDevelopment Product took place. Thereafter, WPD shall furnish to CNS Development Fees no later than forty-five days after the end of each\nCalendar Quarter for the Sale of Development Products through the end of such Calendar Quarter and shall further furnish CNS with a written\nstatement setting forth an accounting showing the calculation of the Development Fees.\nARTICLE 3\nINFORMATION AND USE\n3.1 WPD shall furnish CNS with written reports summarizing the progress of the research and development conducted under the\nSublicense Agreement related to the Development Products on a quarterly basis.\n3.2 The Parties agree to a mutual exchange of any data, information or know-how resulting from the research and development of the\nDevelopment Products.\nARTICLE 4\nOTHER COMPENSATION",
  "parties": "Agreement without prior and express authorization, in writing, by CNS. If WPD, or any of its affiliates, is authorized to engage or use\nsubcontractors for such work, such party and each of its affiliates so involved agrees to obtain a commitment from the subcontractor to comply\nwith the FCPA and any other anti-bribery or anti-corruption law.\n4\nSource: CNS PHARMACEUTICALS, INC., 8-K, 3/26/2020\n\nand authority to enter into and perform under this Agreement.\nCNS Pharmaceuticals, Inc.\nBy____ /s/ John Climaco ___________________\nJohn Climaco, CEOWPD Pharmaceuticals SP. z o.o.\nBy__ /s/ Mariusz Olejniczak ___________\nMariusz Olejniczak, President\n5\nSource: CNS PHARMACEUTICALS, INC., 8-K, 3/26/2020\n\nARTICLE 7\nREPRESENTATIONS, WARRANTIES AND COVENANTS\n7.1 Each Party represents and warrants that:\n7.1.1 it is duly organized and validly existing under the laws of its state or country of incorporation, and has full corporate power\nand authority to enter into this Agreement and to carry out the provisions hereof\u037e\n7.1.2 it is duly authorized to execute and deliver this Agreement and to perform its obligations hereunder, and the person\nexecuting this Agreement on its behalf has been duly authorized to do so by all requisite corporate action\u037e\n7.1.3 this Agreement is legally binding upon it and enforceable in accordance with its terms\u037e that the execution, delivery and\nperformance of this Agreement by it does not conflict with any Agreement, instrument or understanding, oral or written, to which it is a party or by\nwhich it may be bound, nor violate any material law or regulation of any governmental entity having jurisdiction over it\u037e and\n\nthe affairs, finances and condition of such party and any of its affiliates with the officers of such entities and any of their affiliates in relation to\ntheir compliance with this section, as applicable.\n7.2.4 WPD understands and agrees that CNS may terminate this Agreement immediately and without any early termination\npenalty in the event that WPD, or any of its affiliates, materially violates the FCPA or any other anti-bribery or anti-corruption law. WPD\nunderstands and agrees that, if WPD, or any of its affiliates, intends to use foreign subcontractors to provide any services pursuant to this\nAgreement, such party and each of its affiliates is prohibited from engaging or using subcontractors for performance of services under this\nAgreement without prior and express authorization, in writing, by CNS. If WPD, or any of its affiliates, is authorized to engage or use",
  "key_terms": "acts and things reasonably necessary, if any, in connection with the performance of its obligation hereunder to carry out the intent of this\nAgreement.\n9.2 This Agreement contains the entire understanding of the Parties, and supersedes all prior agreements and understandings between the\nParties. This Agreement may be amended only by a written instrument signed by the Parties.\n9.3 The waiver by any Party of any terms or condition of this Agreement, or any part hereof, shall not be deemed a waiver of any other\nterm or condition of this Termination Agreement, or of any later breach of this Agreement.\n9.4 Any notice required by this Agreement will be given by personal delivery (including delivery by reputable messenger services such as\nFederal Express) or by prepaid, first class, certified mail, return receipt requested, addressed to:\nIf to WPD: If to CNS :\nWPD Pharmaceuticals sp. z o.o CNS Pharmaceuticals, Inc.\nAttention: CEO Attention: CEO\n\nARTICLE 7\nREPRESENTATIONS, WARRANTIES AND COVENANTS\n7.1 Each Party represents and warrants that:\n7.1.1 it is duly organized and validly existing under the laws of its state or country of incorporation, and has full corporate power\nand authority to enter into this Agreement and to carry out the provisions hereof\u037e\n7.1.2 it is duly authorized to execute and deliver this Agreement and to perform its obligations hereunder, and the person\nexecuting this Agreement on its behalf has been duly authorized to do so by all requisite corporate action\u037e\n7.1.3 this Agreement is legally binding upon it and enforceable in accordance with its terms\u037e that the execution, delivery and\nperformance of this Agreement by it does not conflict with any Agreement, instrument or understanding, oral or written, to which it is a party or by\nwhich it may be bound, nor violate any material law or regulation of any governmental entity having jurisdiction over it\u037e and\n\nopportunity to challenge or limit the disclosure requirement and to seek confidential treatment or protection order, and that the Confidential\nInformation so disclosed shall remain otherwise subject to the confidentiality and non-use obligations set forth above in this section. Particular\nConfidential Information shall not be deemed to come under any of the above exceptions merely because it is embraced by more general information\nthat is or becomes subject to any of the above exceptions.\n5.2 Subject to full compliance with Section 5.3 below, either party may disclose the other party\u2019s Confidential Information to its employees,\nconsultants and affiliates who have a need to know such information in order to satisfy such Parties obligations under this Agreement. Such\nemployees, consultants and affiliates shall be required to agree to maintain the confidentiality of such information pursuant to terms no less\nrestrictive that the ones set forth herein.\n\nARTICLE 8 INDEMNIFICATION\n8.1 WPD hereby agrees to hold harmless and indemnify CNS, its officers, affiliates, employees, and agents (the \u201c CNS Indemnitees \u201d) from\nand against any and all third party claims, demands, causes of actions, costs of suit and reasonable and documented attorney\u2019s fees (collectively\n\u201cClaims \u201d) caused by, arising out of, or resulting from WPD\u2019s, its employees, agents\u2019, affiliates\u2019, licensees\u2019, sublicensees\u2019 or subcontractors\u2019 (i)\nnegligence or willful misconduct\u037e (ii) breach of any warranty or representations set forth herein\u037e (iii) breach or alleged breach of third party\nintellectual property rights\u037e and (iv) use or sale of Development Products.\nARTICLE 9\nMISCELLANEOUS\n9.1 The Parties shall execute and deliver any and all additional papers, documents, and other instruments and shall do any and all further\nacts and things reasonably necessary, if any, in connection with the performance of its obligation hereunder to carry out the intent of this\nAgreement."
}